Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 27,986 | 28,563 | 27,872 | 26,280 | 25,800 |
| Gross Profit | 27,986 | 28,563 | 27,872 | 26,280 | 25,800 |
| Operating Expenses | 67,885 | 76,999 | 76,572 | 72,582 | 69,232 |
| Operating Income | -39,899 | -48,436 | -48,700 | -46,302 | -43,432 |
| Other Income | 2,337 | 834 | 1,550 | 625 | 2,865 |
| Pre-tax Income | -37,562 | -47,602 | -47,150 | -45,677 | -40,567 |
| Income Tax | -66 | 86 | 24 | 262 | 108 |
| Net Income Continuous | -37,496 | -47,688 | -47,174 | -45,939 | -40,675 |
| Minority Interests | N/A | N/A | -5 | -6 | -71 |
| Net Income | $-37,496 | $-47,688 | $-47,169 | $-45,933 | $-40,604 |
| EPS Basic Total Ops | -0.25 | -0.33 | -0.33 | -0.32 | -0.26 |
| EPS Basic Continuous Ops | -0.26 | -0.33 | -0.33 | -0.32 | -0.26 |
| EPS Diluted Total Ops | -0.25 | -0.33 | -0.33 | -0.32 | -0.26 |
| EPS Diluted Continuous Ops | -0.26 | -0.33 | -0.33 | -0.32 | -0.26 |
| EBITDA(a) | $-34,590 | $-43,183 | $-43,502 | $-41,580 | $-39,249 |